TCR Meeting at the University of Antwerp

On the 12th of December 2018, Audacis will organise the first Antwerp TCR meeting.

Practical info

  • Date: 12 December 2018
  • Venue: UAntwerp, Hof van Liere, Prinsstraat 13, Antwerp
    • F. de Tassiszaal (2nd floor)
    • A. Dürerzaal (2nd floor)
  • Doors open at 08:30
  • Registration is closed


  • There will be the opportunity for three researchers to present their latest TCR related work via an oral presentation. 
  • If you are interested, send your abstract (max 300 words) to before the 30th of November.

How to book a hotel

(please follow the steps in the right order)

  1. Go to the online booking tool
  2. First enter the discount code UAACB18 and click on ‘Validate’
  3. Then enter the arrival and departure dates and click on ‘Search’
  4. You’ll see an overview of all available hotels and their Best Available Rate -10%,  at that moment, including any cancellation conditions
  5. Choose a hotel and book your room

With thanks to the Antwerp Convention Bureau (ACB)


  • 08.30-09.00: Registration
  • 09.00-09.10: Benson Ogunjimi (Antwerp) – Welcome
  • 09.10-10.00: Paul Thomas (Memphis)- T cell receptors and the limits of specificity
  • 10.00-10.40: Phil Bradley (Seattle)- 3D structure-based approaches to T cell repertoire analysis
  • 10.40-11.10: break
  • 11.10-11.50: Victor Greiff (Oslo)- Pattern detection in immune repertoires
  • 11.50-12.30: Pieter Meysman (Antwerp) - Supervised and unsupervised epitope-specificity learning for TCR sequences
  • 12.30-13.00: Leon Eyrich Jessen (Lyngby) - Prediction models for TCR-pMHC interactions
  • 13.00-14.00: Lunch
  • 14.00-14.30: Wouter Scheper (Amsterdam) - Low and variable tumor-reactivity of the intratumoral TCR repertoire in human cancers
  • 14.30-15.00: Lisanne Lutter (Utrecht) - Juvenile Idiopathic Arthritis: T cell clones in time and space
  • 15.00-15.30: Pieter Peeters (Beersel) - Immune Repertoire Analysis in Rheumatoid Arthritis
  • 15.30-16.00: break
  • 16.00-16.30: Viggo Van Tendeloo (Antwerp) - TCR engineering in oncology
  • 16.30-17.00: David Vermijlen (Brussels) - Insight into the development of human gammadelta T cells by high-throughput TCR/CDR3 sequencing